Abstract
Retinoid X receptor (RXR) antagonists are not only useful as chemical tools for biological research, but are also candidate drugs for the treatment of various diseases, including diabetes and allergies, although no RXR antagonist has yet been approved for clinical use. In this review, we present a brief overview of RXR structure, function, and target genes, and describe currently available RXR antagonists, their structural classification, and their evaluation, focusing on the latest research.
Original language | English |
---|---|
Article number | 2354 |
Journal | International journal of molecular sciences |
Volume | 19 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 10 2018 |
Keywords
- Antagonists
- Heterodimers
- Ligands
- Modulators
- Non-permissive
- Permissive
- RXR
- Retinoid X receptor
- Structural classification
- TRXR
ASJC Scopus subject areas
- Catalysis
- Molecular Biology
- Spectroscopy
- Computer Science Applications
- Physical and Theoretical Chemistry
- Organic Chemistry
- Inorganic Chemistry